companydata.dkcompanydata.dk

PHARMA MEDICO ApS: Financial statements 2022

CVR: 28665741

Source: annual report 2022, Danish Business Authority

01/01/2022 – 31/12/2022

PHARMA MEDICO ApS (CVR 28665741) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 30,301,123 and a net result of DKK 16,438,049 compared with DKK 10,382,727 the year before. That is an increase of 57.5% compared with the year before. Equity in the 2022 report amounted to DKK 51,510,862. The solvency ratio was 80.8%. The company had 9 employees in the financial year.

Gross Profit
DKK 30,301,123
Profit/Loss
DKK 16,438,049
Equity
DKK 51,510,862
Total Assets
DKK 63,766,552
Employees
9

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2022-30.3 mio.16.4 mio.51.5 mio.9
2021-19.2 mio.10.4 mio.39.6 mio.10
2020-10.7 mio.2 mio.29.2 mio.10
2019-13.7 mio.4.8 mio.27.2 mio.11
2018-15.1 mio.5.8 mio.25.5 mio.10

Official annual report

View the official annual report directly on the page with a Pro subscription.

Keep an eye on PHARMA MEDICO ApS

Get notified instantly about new financial statements, ownership changes, management changes and status changes.

Set up monitoring

Events in 2022

PHARMA MEDICO ApS: The 2021 annual report is outJul 5, 2022

PHARMA MEDICO ApS has published its annual report for 2021. Gross profit came to DKK 19,238,058, and the net result was DKK 10,382,727.

About PHARMA MEDICO ApS

PHARMA MEDICO ApS is a Danish company of the type Anpartsselskab based in Aarhus C, founded in 2006. The company is registered under the industry Fremstilling af farmaceutiske råvarer. The company was previously named PHARMA MEDICO US ApS. The management consists of Morten Christensen. The company is owned by G.WAVE ApS and Pharma Medico UK Limited. The company has 9 employees (2026). In 2025, the company reported a gross profit of DKK 32,265,731 and a net result of DKK 15,407,736 compared with DKK 8,608,967 the year before. Equity in the 2025 report amounted to DKK 63,546,192.

Source: annual report 2025, Danish Business Authority